Related Experiment Videos
Angiogenesis in embryos and ischemic diseases
G Breier1, A Damert, K H Plate
1Department of Molecular Cell Biology, Max Planck Institute for Physiological and Clinical Research, Bad Nauheim, Germany. GBreier@kerckhoff.mpg.de
Thrombosis and Haemostasis
|July 1, 1997
Summary
Vascular endothelial growth factor (VEGF) is crucial for blood vessel formation during embryonic development. Inhibiting VEGF signaling can prevent abnormal blood vessel growth in diseases, making it a target for anti-angiogenic therapy.
Area of Science:
- Developmental Biology
- Molecular Biology
- Oncology
Background:
- Blood vessel formation (angiogenesis) is regulated by growth factors and their receptors.
- Key signaling systems include Vascular Endothelial Growth Factor (VEGF) with its receptors (Flt-1/VEGFR-1, Flk-1/VEGFR-2) and Angiopoietin-1 with its receptor (Tie-2).
- These molecules are vital for embryonic vascular development.
Purpose of the Study:
- To investigate the role of VEGF and Angiopoietin-1 signaling in embryonic vascular development.
- To explore the involvement of the VEGF signaling system in pathological angiogenesis.
- To assess the therapeutic potential of targeting VEGF signaling for anti-angiogenic therapy.
Main Methods:
- Gene inactivation studies in mouse embryos to assess the necessity of these signaling molecules.
- Analysis of gene expression patterns during embryogenesis.
- Experimental inhibition of VEGF signaling in models of angiogenesis-dependent diseases.
Main Results:
- Inactivation of genes for VEGF, its receptors, or Angiopoietin-1 leads to severe vascular defects and embryonic lethality.
- VEGF signaling is implicated in pathological neovascularization in diseases like retinopathy and solid tumors.
- Inhibition of VEGF signaling effectively reduces neovascularization in these pathological conditions.
Conclusions:
- The VEGF and Angiopoietin-1 signaling pathways are essential regulators of embryonic blood vessel formation.
- The VEGF signaling system plays a significant role in pathological angiogenesis.
- Targeting VEGF signaling offers a promising strategy for anti-angiogenic therapies.